Research Paper Volume 12, Issue 23 pp 24333—24344
Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer
Figure 4. Somatic mutations in 171 patients treated by surgery and adjuvant chemotherapy. (A) Co-occurring and exclusive genes in mutation profiles. (B) Potential druggable gene categories and top five involved genes. (C) Enrichment of known oncogenic signaling pathways in patients with gastric cancer (D).